To address this deficiency, we investigated SOX2, OCT4, and NANOG expression in a panel of ovarian cancer cell lines to identify correlations with growth properties, spheroid-forming potential, traditional TIC marker expression, tumorigenesis, and chemoresistance. Here, SOX2 is linked to ovarian carcinoma.